Sales decline 16.36% to Rs 17.43 crore
Net profit of Jenburkt Pharmaceuticals rose 1583.33% to Rs 1.01 crore in the quarter ended June 2020 as against Rs 0.06 crore during the previous quarter ended June 2019. Sales declined 16.36% to Rs 17.43 crore in the quarter ended June 2020 as against Rs 20.84 crore during the previous quarter ended June 2019. ParticularsQuarter EndedJun. 2020Jun. 2019% Var.Sales17.4320.84 -16 OPM %3.56-2.98 -PBDT1.490.55 171 PBT1.000.02 4900 NP1.010.06 1583Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
